[Correspondence] Communication: the missing pillar of clinical trial governance
Source 柳叶刀 Lancet9d ago
Summary
On Sept 2, 2026, negative results of the phase 3 ASPIRE trial (NCT06617429) of apazunersen in Angelman syndrome were announced in a press release issued after…
We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.
Open original- Desk
- Health
- Region
- United Kingdom
- Language
- English
- Item ID
- health-c32be600
Comments 0 comments
No comments yet. Be the first.